Merck Wants Fosamax Plaintiffs To Cough Up Evidence

Law360, New York (August 12, 2013, 6:56 PM EDT) -- Merck & Co. on Monday asked the federal judge handling multidistrict litigation over the safety of its bone drug Fosamax to force some plaintiffs to substantiate their claims, a move that could see hundreds of cases cut from the MDL.

Lawyers for Merck said that they have identified nearly 600 questionable cases in the MDL. They asked U.S. District Judge John Keenan to enter an order that would require plaintiffs in those cases to substantiate their claims by showing the drug's connections to their alleged illnesses....
To view the full article, register now.